ClassID:

92850

C07C235/64 - CPC Classification

Classification description:

Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring

Recent Application in this class:
#1
20250289780
2025-09-18

N,N'-DIPHENYL-4,4'-BIPHENYLDICARBOXAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT

#2
20250129013
2025-04-24

COMPOUND WITH BROAD-SPECTRUM ANTIBACTERIAL ACTIVITY AND ITS ANTIBACTERIAL COMPOSITION

#3
20250042870
2025-02-06

DP ANTAGONIST

#4
20240360077
2024-10-31

METHODS

#5
20240059646
2024-02-22

RESORCINOL-BASED COMPOUNDS AND USES THEREOF

#6
20230406831
2023-12-21

COMPOUNDS AND METHODS OF INHIBITING BACTERIAL CHAPERONIN SYSTEMS

#7
20230286907
2023-09-14

Carboxamides as modulators of sodium channels

#8
20230150951
2023-05-18

2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS

#9
20230102223
2023-03-30

PHARMACEUTICAL COMPOSITIONS WITH ANTIFLAVIVIRAL ACTIVITY

#10
20230022235
2023-01-26

DUAL ANDROGEN RECEPTOR/AKR1C3 INHIBITORS

#11
20220356147
2022-11-10

COMPOUNDS AND METHODS FOR POTENTIATING COLISTIN ACTIVITY

#12
20220348586
2022-11-03

CANNABINOID DERIVATIVES

#13
20220204468
2022-06-30

DP ANTAGONIST

#14
20220081391
2022-03-17

Methods of treating or controlling cytotoxic cerebral edema consequent to an ischemic stroke

#15
20220073444
2022-03-10

Compounds, Compositions, and Methods for use in Treating Autophagy-Associated Disorders

#16
20220033371
2022-02-03

DP antagonist

#17
20220017476
2022-01-20

STAT3 transcription factor inhibitors and methods of using the same

#18
20210317074
2021-10-14

HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF

#19
20210114973
2021-04-22

PHARMACEUTICAL FORMULATIONS

#20
20210094906
2021-04-01

Carboxamides as modulators of sodium channels

#21
20210078937
2021-03-18

Benzoannulene derivatives as antiviral agents

#22
20210053909
2021-02-25

Antimicrobial compound and use thereof

#23
20200190007
2020-06-18

Compounds, compositions, and methods for use in treating autophagy-associated disorders

#24
20200165214
2020-05-28

Albicidin derivatives, their use and synthesis

#25
20200115325
2020-04-16

Histone acetyltransferase activators and uses thereof

#26
20200101078
2020-04-02

Histone acetyltransferase activators and uses thereof

#27
20200039924
2020-02-06

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

#28
20190160028
2019-05-30

Pharmaceutical compositions with antiflaviviral activity

#29
20190092720
2019-03-28

FUNCTIONALIZED BENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION

#30
20190023645
2019-01-24

“Multi-target” compounds with inhibitory activity towards histone deacetylases and tubulin polymerisation, for use in the treatment of cancer

#31
20190016743
2019-01-17

Compounds for inhibiting cancer and virus

#32
20190016671
2019-01-17

Carboxamides as modulators of sodium channels

#33
20180370905
2018-12-27

Compounds Useful for the Treatment of Metabolic Disorders and Synthesis of the Same

#34
20180360842
2018-12-20

Histone Acetyltransferase Activators and Uses Thereof

#35
20180346409
2018-12-06

Compound, preparation method therefor, applications thereof, corresponding targeted drug delivery system, chemotherapy drugs, and treatment method

#36
20180334424
2018-11-22

Methods of treating cardiac edema, neuromyelitis optica, and hyponatremia

#37
20180244606
2018-08-30

Farnesoid X receptor agonists and uses thereof

#38
20180042873
2018-02-15

NOVEL METHODS

#39
20170334869
2017-11-23

Mitochondrial uncouplers for treatment of metabolic diseases and cancer

#40
20170334837
2017-11-23

DIAMINE COMPOUND, AND HEAT-RESISTANT RESIN OR HEAT-RESISTANT RESIN PRECURSOR USING SAME

#41
20170298010
2017-10-19

Multivalent compounds for use in the treatment and prevention of brain damage

#42
20170183286
2017-06-29

Polymerizable liquid crystal compound, composition for optical film, and optical film, compensation film, antireflective film, and display device including the same

#43
20170182054
2017-06-29

HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF

#44
20170008838
2017-01-12

COMPOUNDS AND COMPOSITIONS FOR USE AS MODULATORS OF TAU AGGREGATION AND ALLEVIATION OF TAUOPATHIES

#45
20160368937
2016-12-22

Phosphonium compound, preparation method thereof, epoxy resin composition including the same, and semiconductor device prepared by using the same

#46
20160318887
2016-11-03

AMIDOPHENOXYPROPANOLAMINES

#47
20160115184
2016-04-28

Phosphonium compound, epoxy resin composition including the same and semiconductor device prepared from the same

#48
20160083337
2016-03-24

Crystal structure of bifunctional transglycosylase PBP1b from and inhibitors thereof

#49
20160046560
2016-02-18

Compounds useful for the treatment of metabolic disorders and synthesis of the same

#50
20150361031
2015-12-17

STAT3 inhibitor

#51
20150342967
2015-12-03

Methods of treating cerebral edema

#52
20150328196
2015-11-19

Amides as modulators of sodium channels

#53
20150232417
2015-08-20

CRYSTAL STRUCTURE OF BIFUNCTIONAL TRANSGLYCOSYLASE PBP1B FROM E. COLI AND INHIBITORS THEREOF

#54
20150191438
2015-07-09

Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives

#55
20150174086
2015-06-25

Niclosamide and its derivatives for use in the treatment of solid tumors

#56
20150133405
2015-05-14

Methods of treating cerebral edema and spinal cord edema

#57
20150126563
2015-05-07

Small molecule inhibitors of the pleckstrin homology domain and methods for using same

#58
20150119426
2015-04-30

Modulators of the relaxin receptor 1

#59
20150087712
2015-03-26

Estrogen receptor ligands and methods of use thereof

#60
20150065469
2015-03-05

Salicylic acid derivatives useful as glucocerebrosidase activators

#61
20140371232
2014-12-18

Cajanine structure analogous compound, preparation method and use

#62
20140221435
2014-08-07

Amides as modulators of sodium channels

#63
20140221411
2014-08-07

2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient

#64
20140187641
2014-07-03

ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF

#65
20130324555
2013-12-05

Method of use of pharmaceutical formulations for the treatment of apicomplexan diseases in animals

#66
20130281444
2013-10-24

Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives

#67
20130281412
2013-10-24

Pharmaceutical composition of salicylanilide-derived small molecules and preparation and application thereof

#68
20130281394
2013-10-24

Chemosensory Receptor Ligand-Based Therapies

#69
20130224790
2013-08-29

Chalcone structure fluorescence dye for embryonic stem cell probe

#70
20130184317
2013-07-18

Small molecule inhibitors of the pleckstrin homology domain and methods for using same

#71
20130121919
2013-05-16

Histone acetyltransferase activators and uses thereof

#72
20120184553
2012-07-19

Compounds

#73
20110275797
2011-11-10

N-acyl anthranilic acid derivative or salt thereof

#74
20110178104
2011-07-21

Anti-Heparin Compounds

#75
20110144066
2011-06-16

Small molecule inhibitors of the pleckstrin homology domain and methods for using same

#76
20110071197
2011-03-24

BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS

#77
20100298276
2010-11-25

Thyroid receptor ligands

#78
20100286215
2010-11-11

BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION

#79
20100215760
2010-08-26

Intrinsically fluorescent carbon nanospheres and a process thereof

#80
20100179326
2010-07-15

Benzamide derivative

#81
20100158996
2010-06-24

ESTER COMPOUND AND MEDICAL USE THEREOF

#82
20100121107
2010-05-13

CRYSTAL STRUCTURE OF BIFUNCTIONAL TRANSGLYCOSYLASE PBP1B FROM E. COLI AND INHIBITORS THEREOF

#83
20100105906
2010-04-29

Substituted pyridines as GPBAR1 agonists

#84
20100075932
2010-03-25

NOVEL SALICYLIC ANILIDES

#85
20100048715
2010-02-25

Insecticidal compounds

#86
20100016630
2010-01-21

Antimicrobial derivatives of anacardic acid and process for preparing the same

#87
20100009290
2010-01-14

Photosensitive Polybenzoxazines and Methods of Making the Same

#88
20090324540
2009-12-31

Compounds and compositions for delivering active agents

#89
20090239919
2009-09-24

Glutamate receptor modulators and therapeutic agents

#90
20090238882
2009-09-24

Carbon-substituted diketopiperazine delivery systems

#91
20090076155
2009-03-19

Modulators (inhibitors/activators) of histone acetyltransferases

#92
20090062271
2009-03-05

Antithrombotic diamides

#93
20090005434
2009-01-01

Salicylic anilides

#94
20080227784
2008-09-18

N-(3,4-disubstituted phenyl) salicylamide derivatives

#95
20080167347
2008-07-10

Ctgf Expression Inhibitor

#96
20080090779
2008-04-17

ANTIALLERGIC AGENTS

#97
20080045546
2008-02-21

Tetradydro-Naphthalene And Urea Derivatives

#98
20080008764
2008-01-10

CARBON-SUBSTITUTED DIKETOPIPERAZINE DELIVERY SYSTEMS

#99
20070276138
2007-11-29

Modulators of peroxisome proliferator activated receptors

#100
20070265268
2007-11-15

Hsp90 family protein inhibitors

#101
20070185110
2007-08-09

Antiallergic agents

#102
20070185059
2007-08-09

Antiallergic agents

#103
20070173498
2007-07-26

Melanin concentrating hormone antagonist

#104
20070123493
2007-05-31

Benzamide derivative

#105
20070087958
2007-04-19

Compounds and compositions for delivering active agents

#106
20070010422
2007-01-11

Compounds and compositions for delivering active agents

#107
20070004794
2007-01-04

Novel salicylic anilides

#108
20060167107
2006-07-27

Modulators (inhibitors/activators) of histone acetyltransferases

#109
20060166990
2006-07-27

Aminobenzophenone compounds

#110
20060166859
2006-07-27

Compounds and compositions for delivering active agents

#111
20060134724
2006-06-22

Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use

#112
20060134130
2006-06-22

Oral drug delivery compositions and methods

#113
20060122243
2006-06-08

Antiallergic

#114
20060100245
2006-05-11

Substituted biphenyl-4-carboxylic acid arylamide analogues

#115
20060084647
2006-04-20

Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof

#116
20060035979
2006-02-16

Inhibitors of transcription factor NF-kappaB

#117
20050272815
2005-12-08

Compounds and compositions for delivering active agents

#118
20050272638
2005-12-08

Compounds and compositions for delivering active agents

#119
20050272036
2005-12-08

Ketones

#120
20050255138
2005-11-17

Active agent transport systems

#121
20050186176
2005-08-25

Compounds and compositions for delivering active agents

#122
20050182134
2005-08-18

Compounds and compositions for treating dysproliferative diseases, and methods of use thereof

#123
20050142156
2005-06-30

Carbon-substituted diketopiperazine delivery systems

#124
20050101671
2005-05-12

Compounds and compositions for delivering active agents

#125
20050080024
2005-04-14

Nitric oxide donating derivatives for the treatment of cardiovascular disorders

#126
20050080021
2005-04-14

Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders

#127
20050075367
2005-04-07

Ester compound and medicinal use thereof

#128
20050042274
2005-02-24

Compounds and compositions for delivering active agents

#129
20050020684
2005-01-27

Modulators of peroxisome proliferator activated receptors

#130
20050004184
2005-01-06

Thyroid receptor ligands